TSTickerStar
Company alerts/SILO
SILO company alerts

SILO updates worth following

TickerStar monitors official filings, investor releases, earnings, and call updates for SILO. Subscribe to SILO alerts to receive concise, source-linked alerts when TickerStar detects a meaningful company update.

Official-source feed

Recent SILO alert previews

TickerStar filters routine noise and surfaces investor-relevant filings, releases, earnings, and call updates.

SEC filingSEC filing

SILO 10-Q filed 2026-11-13 | Key takeaways

SILO filed its 10-Q; the most relevant disclosure change is expanded Customer concentration: One customer accounted for 100% of license fee revenue in the nine months ended September 30, 2026; the mutual termination of the sublicense agreement with Aikido Pharma Inc. on September 2, 2026 resulted in zero revenue during Q3 2026 and recorded a $703,552. Customer concentration: Customer One (Aikido Pharma Inc.) represented 100% of revenue.

Read source-backed brief
Debt offeringSEC filing

Silo Pharma Raises $815K Through Private Placement of Common Stock and Pre-Funded Warrants

Silo Pharma, Inc. entered into securities purchase agreements with accredited investors on November 5, 2026 for a private placement resulting in gross proceeds of approximately $850,000. The transaction included 136,005 shares of common stock at $1.50 per share and pre-funded warrants to purchase up to 430,661 shares at $1.4999 per warrant, exercisable at $0.0001 per share. The private placement closed on November 6, 2026, with net proceeds of approximately $815,000 after deducting placement agent fees and expen...

Read source-backed brief
Company updateOfficial company source

Silo Pharma acquires 'Reputation Endpoints' software and related IP from Larry King in exchange for 150,000 shares

On October 13, 2026, Silo Pharma entered into an asset purchase agreement with Larry King to acquire certain software marketed as 'Reputation Endpoints,' related source code, and assigned intellectual property. In consideration, Silo Pharma issued 150,000 shares of its common stock (par value $0.0001 per share) to Mr. King, with the shares subject to a 12-month lock-up that may end earlier upon a Change in Control or written consent of the Company. The offer and sale was made in reliance on Section 4(a)(2) of th...

Read source-backed brief